Long-term outcomes of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer: a prospective phase II study - Poll - MDSpire

Long-term outcomes of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer: a prospective phase II study

  • By

  • Keiichi Jingu

  • Rei Umezawa

  • Takaya Yamamoto

  • Noriyoshi Takahashi

  • Yu Suzuki

  • Keita Kishida

  • So Omata

  • Hinako Harada

  • Masanobu Takahashi

  • Takashi Kamei

  • Haruo Matsushita

  • July 9, 2026

  • 0 min

Share

Original Source(s)

Long-term outcomes of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer: a prospective phase II study

  • by Keiichi Jingu, Rei Umezawa, Takaya Yamamoto, Noriyoshi Takahashi, Yu Suzuki, Keita Kishida, So Omata, Hinako Harada, Masanobu Takahashi, Takashi Kamei, Haruo Matsushita

  • July 9, 2026

Related Content

Clinical outcomes of plastic versus self-expanding metal stents in malignant hilar biliary obstruction

The emerging roles of eosinophils in immune regulation in health and disease

Metabolic reprogramming networks in the gastric cancer tumor microenvironment: an integrated axis of nutrient competition, metabolic crosstalk, and immunosuppression